Exhibit 10.2

Amendment No. 2 to
Research and Development Agreement

This Amendment No. 2 (this “Amendment No. 2”) to that certain Research and
Development Agreement dated August 11, 2006, as amended effective August 14,
2006 (collectively, the “R&D Agreement”) by and among NuWay Medical, Inc.,
BioLargo Life Technologies, Inc, IOWC Technologies, Inc. and Kenneth Reay Code.
Capitalized terms used herein without definitions shall have the same meanings
as defined in the R&D Agreement.
 
1. The Parties agree that the term of the R&D Agreement shall be extended from
December 31, 2006 to March 31, 2007.
 
2. Except as further modified by this Amendment No. 2, the R&D Agreement is, and
remains, in full force and effect in accordance with its terms.
 
In Witness Whereof, the Parties have executed this Amendment No. 2 as of
December 20, 2006.
  
IOWC TECHNOLOGIES, INC.
 
 
 
 
 
 
 
 
By:  /s/ Kenneth R. Code                               
         President
         
/s/ Kenneth R. Code                                          
KENNETH REAY CODE
 
 
 
NUWAY MEDICAL, INC.
BIOLARGO LIFE
 
TECHNOLOGIES, INC.
 
 
By: /s/ Dennis Calvert                                        
By: /s/ Dennis Calvert                               
     President
    President
 
 

 
 

--------------------------------------------------------------------------------